SG10202004908UA - Compound for use in the prevention and treatment of neurodegenerative diseases - Google Patents
Compound for use in the prevention and treatment of neurodegenerative diseasesInfo
- Publication number
- SG10202004908UA SG10202004908UA SG10202004908UA SG10202004908UA SG10202004908UA SG 10202004908U A SG10202004908U A SG 10202004908UA SG 10202004908U A SG10202004908U A SG 10202004908UA SG 10202004908U A SG10202004908U A SG 10202004908UA SG 10202004908U A SG10202004908U A SG 10202004908UA
- Authority
- SG
- Singapore
- Prior art keywords
- prevention
- compound
- treatment
- neurodegenerative diseases
- neurodegenerative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15196984 | 2015-11-30 | ||
EP16156775.5A EP3207925A1 (en) | 2016-02-22 | 2016-02-22 | Compound for use in the prevention and treatment of neurodegenerative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10202004908UA true SG10202004908UA (en) | 2020-06-29 |
Family
ID=57539219
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202004908UA SG10202004908UA (en) | 2015-11-30 | 2016-11-30 | Compound for use in the prevention and treatment of neurodegenerative diseases |
SG11201803422RA SG11201803422RA (en) | 2015-11-30 | 2016-11-30 | Compound for use in the prevention and treatment of neurodegenerative diseases |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201803422RA SG11201803422RA (en) | 2015-11-30 | 2016-11-30 | Compound for use in the prevention and treatment of neurodegenerative diseases |
Country Status (14)
Country | Link |
---|---|
US (1) | US11179358B2 (ja) |
EP (2) | EP3383381B1 (ja) |
JP (2) | JP7033073B2 (ja) |
CN (1) | CN108601758A (ja) |
AU (1) | AU2016364308B2 (ja) |
CA (1) | CA3003841A1 (ja) |
DK (1) | DK3383381T3 (ja) |
ES (1) | ES2804541T3 (ja) |
HU (1) | HUE050096T2 (ja) |
IL (1) | IL259383B (ja) |
MX (1) | MX2018006631A (ja) |
PT (1) | PT3383381T (ja) |
SG (2) | SG10202004908UA (ja) |
WO (1) | WO2017093363A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2020295671A1 (en) * | 2019-06-18 | 2022-01-20 | Universität Wien | Calixarene compounds and uses thereof |
WO2024112103A1 (ko) * | 2022-11-22 | 2024-05-30 | 경북대학교 산학협력단 | 신경염증성 질환 치료효과를 나타내는 신규 펩타이드 및 이의 용도 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5489612A (en) * | 1991-08-23 | 1996-02-06 | The University Of Alabama At Birmingham Research Foundation | Calixarene chloride-channel blockers |
FR2782007B1 (fr) | 1998-08-05 | 2001-02-23 | Centre Nat Rech Scient | Utilisation des calix(n)arenes pour le traitement des maladies fibrotiques |
US8506959B2 (en) | 2002-11-01 | 2013-08-13 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
ZA200701531B (en) * | 2004-08-09 | 2009-03-25 | Elan Pharm Inc | Prevention and treatment of synucleinopathic and amyloidogenic disease |
FR2888937B1 (fr) | 2005-07-21 | 2012-10-26 | Biomerieux Sa | Procede de detection des fcpa utilisant un agent d'agregation des fcpa et un agent de capture des agregats formes |
CN101460157B (zh) * | 2006-03-29 | 2015-09-02 | 维斯塔实验室有限公司 | 蛋白聚集抑制剂 |
WO2013134371A1 (en) | 2012-03-06 | 2013-09-12 | Neuropore Therapies, Inc. | Methods and compounds to be used in the treatment of neurodegenerative diseases |
-
2016
- 2016-11-30 DK DK16809318.5T patent/DK3383381T3/da active
- 2016-11-30 EP EP16809318.5A patent/EP3383381B1/en active Active
- 2016-11-30 JP JP2018546767A patent/JP7033073B2/ja active Active
- 2016-11-30 SG SG10202004908UA patent/SG10202004908UA/en unknown
- 2016-11-30 PT PT168093185T patent/PT3383381T/pt unknown
- 2016-11-30 US US15/779,559 patent/US11179358B2/en active Active
- 2016-11-30 SG SG11201803422RA patent/SG11201803422RA/en unknown
- 2016-11-30 MX MX2018006631A patent/MX2018006631A/es unknown
- 2016-11-30 CN CN201680069632.0A patent/CN108601758A/zh active Pending
- 2016-11-30 CA CA3003841A patent/CA3003841A1/en not_active Abandoned
- 2016-11-30 AU AU2016364308A patent/AU2016364308B2/en active Active
- 2016-11-30 HU HUE16809318A patent/HUE050096T2/hu unknown
- 2016-11-30 WO PCT/EP2016/079353 patent/WO2017093363A1/en active Application Filing
- 2016-11-30 EP EP20168424.8A patent/EP3735965A1/en not_active Withdrawn
- 2016-11-30 IL IL259383A patent/IL259383B/en unknown
- 2016-11-30 ES ES16809318T patent/ES2804541T3/es active Active
-
2021
- 2021-12-10 JP JP2021200877A patent/JP2022027864A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PT3383381T (pt) | 2020-07-03 |
HUE050096T2 (hu) | 2020-11-30 |
JP2018535272A (ja) | 2018-11-29 |
US11179358B2 (en) | 2021-11-23 |
IL259383A (en) | 2018-07-31 |
EP3735965A1 (en) | 2020-11-11 |
CN108601758A (zh) | 2018-09-28 |
CA3003841A1 (en) | 2017-06-08 |
SG11201803422RA (en) | 2018-06-28 |
US20200360315A1 (en) | 2020-11-19 |
AU2016364308B2 (en) | 2022-03-10 |
EP3383381B1 (en) | 2020-04-08 |
WO2017093363A1 (en) | 2017-06-08 |
JP7033073B2 (ja) | 2022-03-09 |
EP3383381A1 (en) | 2018-10-10 |
IL259383B (en) | 2022-07-01 |
ES2804541T3 (es) | 2021-02-08 |
AU2016364308A1 (en) | 2018-05-17 |
DK3383381T3 (da) | 2020-07-13 |
JP2022027864A (ja) | 2022-02-14 |
MX2018006631A (es) | 2019-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
PT3134125T (pt) | Conjugado-fármaco-anticorpo e sua utilização para o tratamento de cancro | |
PL3277280T3 (pl) | Izomiosmina do zastosowania w leczeniu chorób autoimmunologicznych | |
IL281585B (en) | Selenogalactoside compounds for the prevention and treatment of galectin-related diseases and their use | |
GB201617064D0 (en) | Compounds and their therapeutic use | |
FI3197556T3 (fi) | Koostumus allergisten oireiden ennalta ehkäisemiseksi ja/tai hoitamiseksi | |
EP3107534A4 (en) | Compositions and methods for the treatment of neurodegenerative diseases | |
IL259383A (en) | A compound for use in the prevention and treatment of neurodegenerative diseases | |
EP3283457A4 (en) | Compounds and methods for the treatment of neurodegenerative diseases | |
HUE045532T2 (hu) | Preventív és/vagy terápiás szer immunbetegségekre | |
EP3208262A4 (en) | Compounds derived from 3-alkylamino-1h-indole acrylate, and the use thereof in the treatment of neurodegenerative diseases | |
HK1252359A1 (zh) | 用於治療疼痛的曲唑酮和加巴噴丁的組合 | |
HK1246271A1 (zh) | 用於合成羥基-三甘油酯的方法及其用於預防和治療疾病的用途 | |
PT3413870T (pt) | Igmesina para utilização no tratamento de doença de alzheimer | |
IL252493B (en) | Compounds for use in the prevention or treatment of cancer | |
IL249440B (en) | Pharmaceutical compounds and preparations containing them for the treatment of neurodegenerative diseases | |
EP3377062C0 (en) | AMINONAPHHOQUINONE COMPOUNDS FOR THE TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES | |
PT3191112T (pt) | Compostos de dipeptidilcetoamida e sua utilização para o tratamento e/ou prevenção da acumulação de gordura | |
IL257689B (en) | Pharmaceutical preparations and methods for treating diseases related to lack of oxygen | |
GB201518489D0 (en) | Methods for the treatment and prevention of ebola |